Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma

NCT02654990 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
248
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

pharmaand GmbH